NO962596L - Nytt tumorsupressorgen - Google Patents

Nytt tumorsupressorgen

Info

Publication number
NO962596L
NO962596L NO962596A NO962596A NO962596L NO 962596 L NO962596 L NO 962596L NO 962596 A NO962596 A NO 962596A NO 962596 A NO962596 A NO 962596A NO 962596 L NO962596 L NO 962596L
Authority
NO
Norway
Prior art keywords
dna
proteins
methods
protein
antibodies
Prior art date
Application number
NO962596A
Other languages
English (en)
Other versions
NO962596D0 (no
Inventor
Wen-Hwa Lee
Phang-Lang Chen
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of NO962596D0 publication Critical patent/NO962596D0/no
Publication of NO962596L publication Critical patent/NO962596L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4736—Retinoblastoma protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Denne oppfinnelsen er en iso- lert og renset DNA-sekvens som koder for et Rb-bindende protein som omfatter en undersekvens med minst 60% homologi med ni tetratrikopeptidgjentakelser i den C-terminale ende, med det forbehold at sekvensen koder hverken for S. pomie gjærprotein nuc2, Rspergillus nidulans protein bimA eller S. cerevislae gjær- protein CDC27, vektorer som inneholder DNA-en, DNA-prober basert på DNA-en og fremgangsmåter for behandling hvor DNA- en og vektorene benyttes. Denne oppfin- nelsen er også rettet mot proteiner som DNA-en koder for, fremgangsmåter for behandling hvor proteinene benyttes, og fremgangsmåter for uttrykking av pro- teinene. Endelig er denne oppfinnelsen rettet mot antistoffer mot proteinene, hybridomer som produserer de mono- klonale antistoffene og diagnostiske fremgangsmåter hvor antistoffene benyt- tes.
NO962596A 1993-12-20 1996-06-19 Nytt tumorsupressorgen NO962596L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17058693A 1993-12-20 1993-12-20
PCT/US1994/014813 WO1995017198A1 (en) 1993-12-20 1994-12-20 A novel tumor suppressor gene

Publications (2)

Publication Number Publication Date
NO962596D0 NO962596D0 (no) 1996-06-19
NO962596L true NO962596L (no) 1996-08-19

Family

ID=22620468

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962596A NO962596L (no) 1993-12-20 1996-06-19 Nytt tumorsupressorgen

Country Status (14)

Country Link
EP (1) EP0735889A4 (no)
JP (1) JPH09510343A (no)
CN (1) CN1138295A (no)
AU (1) AU1517495A (no)
BR (1) BR9408357A (no)
CA (1) CA2178745A1 (no)
CZ (1) CZ178396A3 (no)
FI (1) FI962558A7 (no)
HU (1) HUT74413A (no)
NO (1) NO962596L (no)
NZ (1) NZ278745A (no)
PL (1) PL315172A1 (no)
SK (1) SK76896A3 (no)
WO (1) WO1995017198A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747282A (en) * 1994-08-12 1998-05-05 Myraid Genetics, Inc. 17Q-linked breast and ovarian cancer susceptibility gene
CN1054399C (zh) * 1997-11-07 2000-07-12 中国科学院上海生物化学研究所 一个与抗癌基因p53相作用的人类新基因p53bp3
AU771619B2 (en) 1998-06-30 2004-04-01 Genset S.A. A nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid
DE60041257D1 (de) * 1999-07-05 2009-02-12 Cropdesign Nv Cdc27-homologe aus arabidopsis thaliana
AU7769200A (en) * 1999-10-18 2001-04-30 Shanghai Bio Road Gene Development Ltd. Novel polypeptide, human retinoblastoma binding protein 20 and polynucleotide encoding it
CN1333255A (zh) * 2000-07-07 2002-01-30 上海博德基因开发有限公司 一种新的多肽——人视网膜瘤结合蛋白19.91和编码这种多肽的多核苷酸

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology

Also Published As

Publication number Publication date
CZ178396A3 (en) 1997-03-12
HUT74413A (en) 1996-12-30
CN1138295A (zh) 1996-12-18
NO962596D0 (no) 1996-06-19
FI962558A0 (fi) 1996-06-19
WO1995017198A1 (en) 1995-06-29
CA2178745A1 (en) 1995-06-29
HU9601686D0 (en) 1996-08-28
PL315172A1 (en) 1996-10-14
EP0735889A4 (en) 1999-04-14
FI962558L (fi) 1996-06-19
JPH09510343A (ja) 1997-10-21
FI962558A7 (fi) 1996-06-19
SK76896A3 (en) 1997-02-05
NZ278745A (en) 1997-09-22
EP0735889A1 (en) 1996-10-09
AU1517495A (en) 1995-07-10
BR9408357A (pt) 1997-08-26

Similar Documents

Publication Publication Date Title
Clegg et al. Haemoglobin Icaria, a new chain-termination mutant which causes α thalassaemia
NL300153I1 (nl) Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-constructen.
IL96907A0 (en) Proteins produced by human lymphocytes,a dna sequence coding for said proteins and their pharmaceutical and biological application
ATE182901T1 (de) Für androgen-rezeptor-protein kodierende dna
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
NZ279963A (en) Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946
ATE106940T1 (de) Für das polypeptid des t-zellantigenreceptors kodierende nukleinsäure.
DE69117949D1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
DK0948604T3 (da) Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet
FR2660757B1 (fr) Procede d'identification ou de dosage de proteines et applications.
DK0687180T3 (da) Fremgangsmåde til påvisning og behandling af individer, som har unormale celler, som udtrykker HLC-A2/tyrosinasepeptid-anti
CU23412A3 (es) Diagnóstico y tratamiento de enfermedades utilizando anticuerpos anti-anti-receptor de células t vbeta o péptidos que son reconocidos por dichos anticuerpos, y proteína reguladora de la secreción endocrina 1 (prse1)
NO962596L (no) Nytt tumorsupressorgen
DE69426209D1 (de) Stannius- körperchen -protein, stanniocalcin
DE69529272D1 (de) MONOKLONALER ANTIKÖRPER GEGEN DAS HUMANE Mx-PROTEIN MxA
AU5327198A (en) Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
Alais et al. Human casein and its caseino-glycopeptide
GB9401689D0 (en) Diagnosis and treatment of endocarditis
KR860006484A (ko) 단백질 또는 당단백질의 제조방법
DK0616642T3 (da) Hidtil ukendte thrombininhibitoriske proteiner fra landblodigler
TUINMAN et al. Analysis of the amino acid sequence of peptides by mass spectrometry an ion notation proposal
Stockell Comparative studies on tryptic digests of myoglobins
DE50015355D1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
EP0315081A3 (en) Anti-coagulating protein pp4-x, its preparation and use
FR2795414B1 (fr) Polypeptide icbp90 et ses fragments et polynucleotides codant lesdits polypeptides et applications au diagnostic et au traitement du cancer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application